Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients

Sponsor
Universidade Federal de Pernambuco (Other)
Overall Status
Unknown status
CT.gov ID
NCT01649310
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Other)
21
1
1
46
0.5

Study Details

Study Description

Brief Summary

The whole body vibration offers better treatment adherence among the elderly, minimizing effort and additional stress to the cardiovascular system and skeletal muscles compared to conventional exercise programs.

Hypothesis: Patients with COPD undergoing a training program on the whole body vibration show better performance in the 6MWT and improvement in muscle strength.

Condition or Disease Intervention/Treatment Phase
  • Other: whole body vibration
N/A

Detailed Description

In the elderly and in COPD patients weight loss includes sarcopenia, resulting from aging itself or due to disuse or disease states associated with and represents the reduction in muscle mass, leading to decreased strength and endurance, with repercussions on the functional abilities of the same. It reduces the power and muscle strength with aging which represent decreasing to carry out daily physical tasks.

In COPD, exacerbations worsen the loss of muscle mass, affecting the respiratory and peripheral muscles, exercise capacity and survival rates, and in the case of severe malnutrition in advanced cases of the disease, the implications of this state are disability which occur between 10-15% in those with mild obstruction and 25% in moderate to severe obstructive and are associated with worse prognosis.

The whole body vibration could be an efficient combination of training methods for elderly patients and is based on the generation of sinusoidal vibrations offered by a platform, which stimulates the muscle spindles resulting in activation of neurons α engines and develop muscle contractions, presenting itself as an alternative to conventional treatment for muscular endurance as well as improving physical fitness

Study Design

Study Type:
Interventional
Anticipated Enrollment :
21 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effects of Whole Body Vibration Training in Chronic Obstructive Pulmonary Disease (COPD) Patients: a Randomized Controlled Trial
Study Start Date :
Feb 1, 2012
Anticipated Primary Completion Date :
Dec 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: WVB Training

Other: whole body vibration
Exercises on the platform will be made in semi-squat position, static. In the first month training will be held for 10 minutes for the exercises on the platform, 30 seconds of vibration of low intensity, interspersed with rest 60 seconds while standing beside the platform. In the second month training will be held for 15 minutes, lasting 60 seconds of vibration and 30 seconds of rest in standing beside the platform. For the first two weeks training will have low intensity and the last two weeks training will have higher vibration. In the third month, training will be held for 20 minutes, 60 seconds of vibration and 30 seconds of rest while standing beside the platform. The intensity of the vibration will be high.
Other Names:
  • Equipment: Power Plate my3
  • Outcome Measures

    Primary Outcome Measures

    1. Walked distance in 6MWT [Increase in distance walked at baseline and 3 months]

      Change from baseline in distance walked test 6-minute walk test at 3 months.

    Secondary Outcome Measures

    1. Respiratory muscle strength [Change from baseline in respiratory muscle strength at 3 months]

      Increase in respiratory muscle strength.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Smoking history, occupational or environmental exposure to pollutants and / or cough, hypersecretion or dyspnea,

    • FEV1 <80% predicted and postbronchodilator FEV1/FVC <70% to confirm the diagnosis of airway obstruction air not fully reversible bronchodilator therapy,

    • Have the ability to perform the walk test, 6 minutes, absence of comorbidities that preclude the achievement of effort (hypertension, severe pulmonary hypertension, myocardial infarction, congestive heart failure, severe dyspnea)

    • Preserved cognitive functioning,

    • Clinically stable during the study period

    Exclusion Criteria:
    • Have cognitive impairment, hearing or visual compromise the response to the questionnaires used in this study

    • Make modifications to the appliance neuro-musculo-skeletal system that prevents the completion of the 6MWT

    • Be participating in physical activity programs.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Universidade Federal de Pernambuco Recife Pernambuco Brazil 50.740-560

    Sponsors and Collaborators

    • Universidade Federal de Pernambuco
    • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Patrícia Érika de Melo Marinho, Professor, Universidade Federal de Pernambuco
    ClinicalTrials.gov Identifier:
    NCT01649310
    Other Study ID Numbers:
    • Patricia
    First Posted:
    Jul 25, 2012
    Last Update Posted:
    Dec 3, 2014
    Last Verified:
    Dec 1, 2014
    Keywords provided by Patrícia Érika de Melo Marinho, Professor, Universidade Federal de Pernambuco
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 3, 2014